Paradigm shift in AMD biology may lead to new class of anti-angiogenics

A new biomarker, “CCR3”, has been found to associate specifically with choroidal neovascularisation but not with normal retinal vasculature in research reported from the University of Kentucky. The finding marks a significant development in the understanding of AMD and will likely lead to the development of both diagnostic tools for early disease